3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Psychoses, Drug in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abi-Dargham, A; Baldwin, RM; Charney, DS; D'Souza, CD; Erdos, J; Fingado, C; Gil, R; Innis, RB; Krystal, JH; Laruelle, M; McCance, E; Rosenblatt, W; Seibyl, JP; van Dyck, CH; Zoghbi, SS | 1 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Psychoses, Drug
Article | Year |
---|---|
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
Topics: Adult; Amphetamine; Animals; Benzamides; Corpus Striatum; Dopamine; Dopamine Antagonists; Female; Humans; Male; Papio; Psychoses, Substance-Induced; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 1996 |